Latest Breaking News On - Company or algernon - Page 2 : comparemela.com

Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis

Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomChristopherj moreauJapanese patent officeAlgernon pharmaceuticals incAlgernon pharmaceuticalsCompany or algernonTreating idiopathic pulmonary fibrosisAlgernon neuroscience

Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD

Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomChristopherj moreauCompany or algernonNo securities exchangeChinese patent officeNeither the canadian securities exchangeAlgernon pharmaceuticalsChristopherj moreauceoalgernon pharmaceuticals incAlgernon pharmaceuticals incCanadian securities exchangeTreating non alcoholicAlgernon neurosciencePharmaceuticals incMarket regulator

Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position

Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

British columbiaUnited statesRheinland pfalzUnited kingdomChristopherj moreauNo securities exchangeMerck coAlgernon pharmaceuticals incCompany or algernonDrug administrationMarket researchAlgernon pharmaceuticalsCanadian securities exchangeBellus healthNeither the canadian securities exchangeAfferent pharmaceuticals

Algernon Pharmaceuticals Announces Grant of U S Patent for Repirinast in NAFLD and NASH

VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFUR.

United statesUnited kingdomBritish columbiaChristopherj moreauAlgernon pharmaceuticalsCanadian securities exchangeTrademark officeAlgernon pharmaceuticals incNeither the canadian securities exchangeCompany or algernonUnited states patentTreating non alcoholic steatohepatitisMitsubishi tanabe pharmaZhejiang ausun pharmaceuticalAlgernon neuroscienceMarket regulator

Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement

Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaUnited kingdomChristopherj moreauCompany or algernonAlgernon pharmaceuticals incMaxim groupAlgernon pharmaceuticalsCanadian securities exchangeNo securities exchangeCompanya common shareNeither the canadian securities exchangeEach unitCommon shareEach warrantWarrant share